Halozyme Therapeutics, Inc. HALO
129.82 USD +1.20 (+0.94%)
Nov 4, 2026, 2:00 PM EST
126.86 Day range 130.81
61.63 52-week range 131.18
- YTD
- +92.90%
- 1 year
- +90.78%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 1.40B | 1.02B | 829.25M | 660.12M | 443.31M | |
| 1.17B | 855.91M | 636.89M | 520.81M | 361.90M | |
| 469.01M | 551.48M | 337.57M | 267.53M | 275.90M | |
| 316.89M | 444.09M | 281.59M | 202.13M | 402.71M | |
| 2.56 | 3.43 | 2.10 | 1.44 | 2.74 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 136.42M | 115.85M | 118.37M | 234.69M | 119.22M | |
| 2.53B | 2.06B | 1.73B | 1.84B | 1.10B | |
| 2.48B | 1.70B | 1.65B | 1.67B | 907.48M | |
| 2.14B | 1.51B | 1.50B | 1.51B | 876.67M | |
| 48.81M | 363.82M | 83.81M | 169.80M | 196.95M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 651.56M | 479.06M | 388.57M | 240.11M | 299.44M | |
| -545.81M | -262.72M | -96.91M | -487.00M | -406.29M | |
| -85.17M | -218.86M | -407.99M | 362.37M | 77.86M | |
| -6.97M | -10.70M | -15.29M | 21.20M | -1.46M | |
| 20.57M | -2.52M | -116.33M | 115.48M | -28.98M |